CD19-targeting CAR T-cell immunotherapy yields high responses in treatment-resistant CLL SEATTLE – Dec. Three, two thousand sixteen – In a puny, early phase trial, a high percentage of patients who had tired most traditional treatments for chronic lymphocytic leukemia eyed their tumors shrink or even vanish after an infusion of a very targeted, experimental CAR T-cell immunotherapy developed at Seattle’s ...
Read More »CD19-targeting CAR T-cell immunotherapy yields high responses in treatment-resistant CLL
